Health Canada approves Moderna Covid-19 vaccine for people above 18 years

The different storage and handling requirements of the Moderna COVID-19 vaccine said that it can be distributed to isolated and remote communities, including the territories. 

After a thorough, independent review of Moderna’s submission on Oct 12, Health Canada has determined that the Moderna vaccine meets the Health Department’s stringent safety, efficacy, and quality requirements.

The terms and conditions of the Moderna vaccine authorization require that Health Canada would continuously receive information from the vaccine manufacturer on safety, efficacy, and quality to ensure the benefits of the vaccine continue to be demonstrated through market use. 

Being committed to openness and transparency to support vaccine's authorization, Health Canada said it is publishing a number of documents and added more detailed information including a detailed scientific summary and the full clinical trial data package will be made available in the coming weeks.

Once the vaccine is on the market, Health Canada and the Public Health Agency of the country will closely monitor the safety of the vaccine

The National Advisory Committee on Immunization (NACI) will further support the safe use of the Moderna vaccine by updating its recommendations on the use of COVID-19 vaccines to inform federal, provincial, and territorial immunization programs.

(Reported by Asha Bajaj)